The ICH Q8 guideline ensures a systematic approach to pharmaceutical development by defining globally recognized Quality by Design (QbD) principles to enhance product quality throughout all stages of development.
This course provides a comprehensive overview of Quality by Design (QbD), emphasizing its science-and-risk-based methodology with a patient-centric focus specifically tailored to enhance manufacturing processes. Participants will gain a thorough understanding of QbD terminology, key steps, and the advantages it offers. Additionally, it covers regulatory and industry guidelines, offering valuable insights into linking QbD with the Process Validation lifecycle, including references to influential resources such as the ISPE PQLI Guides.
CEUs are provided once you achieve an 80% passing grade and complete the evaluation.
The course is self-paced. On average, the time required for completion ranges from 1 to 3 hours.